Ok it's the Daily Mail, but I have checked also other sources 😜
A groundbreaking study used a modified Newcastle disease virus, known as NDV-GT, to target cancer cells and stimulate the immune system. The therapy showed promise across multiple advanced cancer types, with the majority of patients experiencing tumor shrinkage or halted growth after a few months of treatment. Researchers altered the virus to coat cancer cells with a sugar that human antibodies attack, triggering an immune response.
While results were encouraging, further clinical trials are needed to confirm its safety and effectiveness. Oncolytic virus therapy, including NDV-GT, represents a potentially transformative approach to treating cancer by focusing on genetic traits rather than tumor location.
Yale develops new form of Immunotherapy...
Invitro study shows Delta Tocotrienol overcomes Docetaxel resistence in PCa
